The European Medicines Agency has approved seven types of biosimilars from 2009 till date, according to data available on its website. While the... ...http://www.financialexpress.com/article/economy/biosimilars-are-the-next-big-thing-for-indian-pharma/23516/
Key benchmark indices edged higher today, 26 December 2014. Volatility was high as key indices swung between gains and losses during the session.... ...http://www.business-standard.com/article/news-cm/key-indices-rise-in-volatile-session-114122600935_1.html
Related to : Cipla Ltd Cipla Ltd BSE 26 Dec 14 | 12:00 AM 622.65 -2.65 (-0.42%) NSE 26 Dec 14 | 12:00 AM 622.80 -2.3 (-0.37%)... ...http://smartinvestor.business-standard.com/market/Marketnews-285028-Marketnewsdet-CIPLA_Order_boost_inhaler_sales_key_triggers.htm
Equity benchmarks closed marginally higher with the Nifty clawing back above the 8200 level on Friday, the first day of January series, supported... ...http://www.moneycontrol.com/news/local-markets/jan-series-begins-nifty-ends-above-8200-amid-low-volumes_1261622.html
It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as... ...http://businesstoday.intoday.in/story/pharma-sector-sun-ranabxy-merger-worth-billions-in-2014/1/213913.html
Discover the difference with...